SOX2 and neoplasm: Utilizing a published scRNA-seq dataset comprising 15 tumor samples and one nasopharynx [14], UMAP visualization revealed that SOX2, NTRK2, LRP6, and PTPRZ1 from our candidate list were predominantly expressed in epithelial and malignant patient cells (Fig. 2A, B).